GlassScriptPhysician profile
Jason J Lee
NPI 1447576467
$4,565.10
in general payments reported to CMS, 2019-2025
31 companies · $1,184 in 2025
The $1,184 reported for 2025 was more than what 80% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $36.76 · 2021: $751 · 2022: $604 · 2023: $929 · 2024: $778 · 2025: $1,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,833 · Education: $57.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,832.84 |
| Education | $57.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,144.27 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $664.09 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Takeda Pharmaceuticals U.S.A., INC. | $397.72 | 2021-2024 | Entyvio, Gattex |
| Merck Sharp & Dohme LLC | $221.05 | 2019-2025 | Zerbaxa |
| Insmed, INC. | $212.57 | 2023-2025 | Arikayce |
| Electromed, INC. | $201.60 | 2021-2024 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $198.45 | 2019-2022 | |
| Abbvie INC. | $197.05 | 2021-2025 | |
| Genzyme Corporation | $171.67 | 2022-2025 | |
| Grifols USA, LLC | $147.74 | 2019-2025 | Prolastin-C Liquid, Gamunex-C |
| Pfizer INC. | $119.43 | 2019-2024 | |
| Philips North America LLC | $95.20 | 2021-2024 | (O58) Sleep Respiratory Care Und |
| Janssen Pharmaceuticals, INC | $93.98 | 2021 | |
| Nestle Healthcare Nutrition INC. | $77.16 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $75.01 | 2019-2023 | Breztri, Tezspire |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $66.66 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $57.48 | 2023 | |
| Baxter Healthcare | $57.22 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Amgen INC. | $52.37 | 2021-2025 | Tezspire |
| Genentech USA, INC. | $39.26 | 2024 | Xolair |
| Csl Behring | $34.65 | 2025 | Hizentra |
| Mallinckrodt Hospital Products INC. | $29.53 | 2023 | Acthar |
| Lilly USA, LLC | $28.51 | 2025 | Omvoh |
| Viatris Specialty LLC | $27.01 | 2025 | Yupelri |
| Janssen Biotech, INC. | $25.93 | 2024 | Tremfya |
| Alk-Abello, INC | $24.70 | 2023 | Odactra, Ragwitek, Grastek |
| Intercept Pharmaceuticals, INC. | $23.10 | 2023 | Ocaliva |
| Ironwood Pharmaceuticals, INC | $22.47 | 2019 | |
| Ardelyx, INC. | $22.03 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.94 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $17.25 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.